Background/purpose: Restrictions for ECMO in neonates include birth weight less than 2. kg (BW <. 2. kg) and/or gestational age less than 34. weeks (GA <. 34. weeks). We sought to describe their relationship on mortality. Methods: Neonates with a primary diagnosis code of CDH were identified in the Extracorporeal Life Support Organization (ELSO) registry, and logistic regression models were used to examine the effect of BW <. 2. kg and GA <. 34. weeks on mortality. Results: We identified 7564 neonates with CDH. The overall mortality was 50%. There was a significantly higher risk of death with unadjusted odds ratio (OR) 2.39 (95% confidence interval [CI]: 1.53-3.74; P <. 0.01) for BW <. 2. kg neonates. The adjusted OR of death for BW <. 2. kg neonates remained significantly high with over two-fold increase in the odds of mortality when adjusted for potential confounding variables (OR 2.11, 95% CI: 1.30-3.43; P <. 0.01). However, no difference in mortality was observed in neonates with GA <. 34. weeks. Conclusions: While mortality among CDH neonates with a BW <. 2. kg was substantially increased, GA <. 34. weeks was not significantly associated with mortality. Effort should be made to identify the best candidates for ECMO in this high-risk group and develop treatment strategies to optimize their survival. Type of study: Case-Control Study, Retrospective Comparative Study. Level of evidence: Level III.
- Low birthweight
- Low gestation
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health